Invesaro

Stocks Health care ELUT

NASDAQ · Health care

Elutia Inc. (ELUT)

Elutia Inc. brought in $12.1M of revenue over the twelve months to June 30, 2026, up 69.0% from a year earlier. Net income was $51.8M, a net margin of 426.9%. In fiscal 2025 capital spending exceeded operating cash flow by $46.7M. At June 30, 2026 it held $19.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Free, no password. An email when ELUT files with the SEC.

Price
$0.84
-0.18% on the day · November 9, 2026
52-week range $0.50 to $1.39
Market cap
$37M
Revenue (last 12 months)
$12.1M
+69.0% year on year
Net margin
426.9%
P/E
1.0
on FY2025 diluted EPS

Key facts about Elutia Inc.

Net worth
Elutia Inc. has a market value (market cap) of $37M at the latest share price, and shareholders' equity of $15.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Cash flow
In fiscal 2025 operations used $44.8M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 14, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Elutia Inc.'s next report was expected around November 5, 2026 and is not on file with the SEC yet.

What Elutia Inc. does

Elutia Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker ELUT.

Revenue and profit by year

Revenue
FY20: $42.9M $42.9M FY20FY20: $42.7M $42.7M FY20FY21: $47.4M $47.4M FY21FY22: $23.8M $23.8M FY22FY23: $24.7M $24.7M FY23FY24: $14.5M $14.5M FY24FY25: $12.3M $12.3M FY25
Net income
FY20: -$11.9M -$11.9M FY20FY20: -$21.8M -$21.8M FY20FY21: -$24.8M -$24.8M FY21FY22: -$32.9M -$32.9M FY22FY23: -$37.7M -$37.7M FY23FY24: -$53.9M -$53.9M FY24FY25: $53.4M $53.4M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$12.3M-$26.9M$53.4M$0.87-$46.7M
2024$14.5M-$30.7M-$53.9M-$1.86-$23.3M
2023$24.7M-$30.5M-$37.7M-$2.07-$22.1M
2022$23.8M-$35.2M-$32.9M-$2.38-$22M
2021$47.4M-$23M-$24.8M-$2.38-$15.8M
2020$42.7M-$13.6M-$21.8M-$8.88-$14.3M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

A report was expected around November 5, 2026 and is not on file yet.

Estimated from its filing rhythm: 52 weeks after its report of November 6, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where ELUT ranks in Health care

Revenue$12.3M
#509 of 751 in Health care · Bottom 32%
Revenue growth-15.0%
#478 of 532 in Health care · Bottom 10%
Net margin434.2%
#1 of 544 in Health care · Top 1%
Free cash flow margin-379.8%
#463 of 490 in Health care · Bottom 6%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Elutia Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 21, 2026
  2. August 14, 2026
  3. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 12% to $2.4M versus the same quarter last year; diluted EPS -$0.17 versus -$0.26.
  4. August 14, 2026
  5. August 13, 2026
  6. August 11, 2026
  7. August 7, 2026
  8. July 20, 2026
  9. June 16, 2026
  10. May 15, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 5.5% to $3.1M versus the same quarter last year; diluted EPS -$0.17 versus -$0.21.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 14, 2026. Insider transactions on SEC

Insider trades

What the people running Elutia Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 6 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
September 10, 2026 Ferguson MatthewCHIEF FINANCIAL OFFICER Exercised options 12,500 - - Form 4
September 10, 2026 Ferguson MatthewCHIEF FINANCIAL OFFICER Shares withheld for tax 4,486 $0.80 $3.6K Form 4
September 10, 2026 Mills C RandalPRESIDENT AND CEO, Director Exercised options 27,083 - - Form 4
September 10, 2026 Mills C RandalPRESIDENT AND CEO, Director Shares withheld for tax 9,718 $0.80 $7.8K Form 4
September 10, 2026 Williams Michelle LeRouxCHIEF SCIENTIFIC OFFICER Exercised options 12,500 - - Form 4
September 10, 2026 Williams Michelle LeRouxCHIEF SCIENTIFIC OFFICER Shares withheld for tax 4,269 $0.80 $3.4K Form 4
June 21, 2026 Mills C RandalPRESIDENT AND CEO, Director Exercised options 22,473 - - Form 4
June 21, 2026 Mills C RandalPRESIDENT AND CEO, Director Shares withheld for tax 8,064 $1.06 $8.5K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns ELUT

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Kevin Rakin13D, may seek influence with 9 related filers 13% 5,244,056 December 15, 2025
Nantahala Capital Management, LLC13G, passive with 2 related filers 9.99% 4,124,854 February 13, 2026
Orin Hirschman13G, passive with 1 related filers 7.6% 3,068,185 January 28, 2026
Knollwood Investment Advisory, LLC13G, passive 6.3% 2,556,724 February 13, 2026

Latest filings below 5%: SilverArc Capital Management, LLC 4.9% (August 14, 2026); Alyeska Investment Group, L.P. 3.18% (February 17, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 39 managers reported a position.

HolderSharesValueChange on quarter
Nantahala Capital Management, LLC6,369,894$6.2M+3,184,947
AIGH Capital Management LLC2,695,644$2.6M-899,606
Knollwood Investment Advisory, LLC2,556,724$2.5M0
Silverarc Capital Management, LLC2,192,980$2.1M-305,040
Vanguard Capital Management LLC1,142,575$1.1M+118,876
Perkins Capital Management Inc694,094$379.9K-62,800
Geode Capital Management, LLC285,229$279.4K-8,167
Corient Private Wealth LP253,500$248.3K+4,468
Renaissance Technologies LLC201,816$197.7K+119,100
Vanguard Fiduciary Trust Co172,446$169K+53,101
BlackRock, Inc.167,857$164.4K+45,784
Birchview Capital, LP165,094$161.7K0
Citadel Advisors LLC123,505$121K+11,400
Rossmore Private Capital120,000$117.6K0
XTX Topco Ltd52,606$51.5K+14,456
Jane Street Group, LLC44,697$43.8K-19,380
Northern Trust Corp44,670$43.8K+17,008
Atom Investors LP44,231$43.3Knew
LRI Investments, LLC25,224$24.7Knew
Brown Advisory Inc20,135$19.7K0

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

7 insiders reported holding 1,655,968 shares in total, about $1.4M at the last price.

HolderSharesAs of
Ferguson MatthewCHIEF FINANCIAL OFFICER 489,903 September 10, 2026
Mills C RandalPRESIDENT AND CEO, Director 464,395 September 10, 2026
Rakin KevinDirector, 10% owner 398,539272,419 held indirectly June 1, 2026
Williams Michelle LeRouxCHIEF SCIENTIFIC OFFICER 126,283 September 10, 2026
Neels Guido JDirector 118,750 January 30, 2026
Colpman DavidDirector 31,098 December 17, 2025
Makes BrigidDirector 27,000 December 17, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about ELUT

What does Elutia Inc. do?

Elutia Inc. is a company in the Health care sector, listed on NASDAQ as ELUT. Its shares trade on NASDAQ under the ticker ELUT.

What is Elutia Inc.'s net worth?

Elutia Inc. has a market value (market cap) of $37M at the latest share price, and shareholders' equity of $15.7M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Elutia Inc. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $51.8M on revenue of $12.1M, a net margin of 426.9%.

How much revenue does Elutia Inc. make?

Over the twelve months to June 30, 2026 Elutia Inc. reported revenue of $12.1M. That is 69.0% more than a year earlier.

When did Elutia Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 14, 2026.

When is Elutia Inc.'s next earnings report?

Elutia Inc.'s next report was expected around November 5, 2026 and is not on file with the SEC yet.

Similar companies

Compare ELUT with

Compare ELUT with any company

Follow ELUT

Get an email when Elutia Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when ELUT files with the SEC.

Where the numbers come from

Financial figures are the values Elutia Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.